BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19219680)

  • 1. A human apolipoprotein E mimetic peptide effectively inhibits HSV-1 TK-positive and TK-negative acute epithelial keratitis in rabbits.
    Bhattacharjee PS; Neumann DM; Hill JM
    Curr Eye Res; 2009 Feb; 34(2):99-102. PubMed ID: 19219680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective treatment of ocular HSK with a human apolipoprotein E mimetic peptide in a mouse eye model.
    Bhattacharjee PS; Neumann DM; Foster TP; Clement C; Singh G; Thompson HW; Kaufman HE; Hill JM
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4263-8. PubMed ID: 18515564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo effects of polyhexamethylene biguanide against herpes simplex virus infection.
    Valluri S; Fleming TP; Laycock KA; Tarle IS; Goldberg MA; Garcia-Ferrer FJ; Essary LR; Pepose JS
    Cornea; 1997 Sep; 16(5):556-9. PubMed ID: 9294689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of (S)-HPMPA against thymidine kinase-deficient herpes simplex virus-keratitis.
    Maudgal PC; De Clercq E; Huyghe P
    Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):243-8. PubMed ID: 8591903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
    Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antimicrobial agent C31G is effective for therapy for HSV-1 ocular keratitis in the rabbit eye model.
    Hill JM; Stern EM; Bhattacharjee PS; Malamud D; Clement C; Rodriguez P; Lukiw WJ; Ochoa AC; Foster TP; Velasco C; McFerrin HE
    Antiviral Res; 2013 Oct; 100(1):14-9. PubMed ID: 23860013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptide monoester ganciclovir prodrugs for treating HSV-1-induced corneal epithelial and stromal keratitis: in vitro and in vivo evaluations.
    Majumdar S; Nashed YE; Patel K; Jain R; Itahashi M; Neumann DM; Hill JM; Mitra AK
    J Ocul Pharmacol Ther; 2005 Dec; 21(6):463-74. PubMed ID: 16386088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A thymidine kinase deficient HSV-2 strain causes acute keratitis and establishes trigeminal ganglionic latency, but poorly reactivates in vivo.
    Stroop WG; Banks MC; Qavi H; Chodosh J; Brown SM
    J Med Virol; 1994 Jul; 43(3):297-309. PubMed ID: 7931192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of cobalt chelates in the rabbit eye model for epithelial herpetic keratitis.
    Asbell PA; Epstein SP; Wallace JA; Epstein D; Stewart CC; Burger RM
    Cornea; 1998 Sep; 17(5):550-7. PubMed ID: 9756451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 2, heparin and suramin reduce epithelial ulcer development in experimental HSV-1 keratitis.
    Rieck P; Denis J; Peters D; Hartmann C; Pouliquen Y; Courtois Y
    Graefes Arch Clin Exp Ophthalmol; 1997 Nov; 235(11):733-40. PubMed ID: 9407232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antiviral medications on herpetic epithelial keratitis in mice.
    Komoto S; Higaki S; Fukuda M; Shimomura Y
    Jpn J Ophthalmol; 2015 May; 59(3):194-200. PubMed ID: 25707352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of thymidine kinase gene in herpes simplex virus type 1: analysis of clinical isolates from herpetic keratitis patients and laboratory strains.
    Kudo E; Shiota H; Naito T; Satake K; Itakura M
    J Med Virol; 1998 Oct; 56(2):151-8. PubMed ID: 9746072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.
    Romanowski EG; Bartels SP; Gordon YJ
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical treatment with nerve growth factor in an animal model of herpetic keratitis.
    Lambiase A; Coassin M; Costa N; Lauretti P; Micera A; Ghinelli E; Aloe L; Rama P; Bonini S
    Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):121-7. PubMed ID: 17479276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of herpes simplex virus DNA in rabbit corneal cells.
    Cantin E; Chen J; Willey DE; Taylor JL; O'Brien WJ
    Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2470-5. PubMed ID: 1321797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus genome quantification in two patients who developed herpetic epithelial keratitis during treatment with antiglaucoma medications.
    Deai T; Fukuda M; Hibino T; Higaki S; Hayashi K; Shimomura Y
    Cornea; 2004 Mar; 23(2):125-8. PubMed ID: 15075880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phosphonylmethoxyalkyl-purine and -pyrimidine derivatives on TK+ and TK- HSV-1 keratitis in rabbits.
    Maudgal PC; De Clercq E
    Antiviral Res; 1991 Jul; 16(1):93-100. PubMed ID: 1663731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of polyclonal antibodies for treatment of ocular herpes simplex infection.
    Epstein SP; Nurozler M; Smetana CR; Asbell PA
    Cornea; 2001 Jul; 20(5):495-500. PubMed ID: 11413405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyclovir-resistant bilateral keratitis associated with mutations in the HSV-1 thymidine kinase gene.
    Bodaghi B; Mougin C; Michelson S; Agut H; Dighiero P; Offret H; Frau E
    Exp Eye Res; 2000 Oct; 71(4):353-9. PubMed ID: 10995556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCR assessment of HSV-1 corneal infection in animals treated with rose bengal and lissamine green B.
    Stroop WG; Chen TM; Chodosh J; Kienzle TE; Stroop JL; Ling JY; Miles DA
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2096-102. PubMed ID: 10892849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.